Manesh Girn is a psychedelic neuroscientist firmly rooted in both academia and industry. He joins us on the Psychedelic Spotlight podcast today to speak about his research into neuroimaging of the brain while subjected to psychedelic states, as well as to speak about the nuances of biotech companies seeking to monopolize certain compounds. We discuss the merit of whether or not psychedelic researchers should have subjective experiences with the compounds they’re researching, and hear about the blindspots in the psychedelic research community. You can keep in touch with Manesh over on:Twitter: @mgirnneuroInstagram: @maneshgirnAnd check out his relevant links on Link Tree: https://linktr.ee/thepsychedelicscientist